Alto Neuroscience, Inc.
ANRO
$24.63
$0.100.41%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.18M | -14.18M | -17.71M | -15.17M | -15.20M |
| Total Depreciation and Amortization | 157.00K | 164.00K | 169.00K | 171.00K | 170.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.41M | 2.80M | 2.46M | 3.10M | 1.91M |
| Change in Net Operating Assets | 2.10M | 1.30M | 1.30M | -4.66M | 99.00K |
| Cash from Operations | -11.52M | -9.92M | -13.78M | -16.56M | -13.02M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -24.00K | -506.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 0.00 | -24.00K | -506.00K |
| Total Debt Issued | 0.00 | 750.00K | 0.00 | 19.69M | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -10.21M | -- |
| Issuance of Common Stock | 50.35M | 153.00K | 0.00 | 198.00K | 49.00K |
| Repurchase of Common Stock | -167.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -750.00K | 613.00K | -546.00K | 0.00 |
| Cash from Financing | 50.19M | 153.00K | 613.00K | 9.13M | 49.00K |
| Foreign Exchange rate Adjustments | -1.00K | -4.00K | -3.00K | -22.00K | 6.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.67M | -9.77M | -13.17M | -7.48M | -13.47M |